-
Pot, Meet Kettle: Wells Fargo Says Valeant's Stock Too Risky In Light Of Potential Fraud Charges
Tuesday, November 1, 2016 - 11:48am | 411Read More...Wells Fargo reiterated its Underperform rating on Valeant Pharmaceuticals Intl Inc (NYSE: VRX), saying the new Bloomberg report over potential accounting fraud charges on the company makes the stock further risky for investment. Bloomberg reported that U.S. authorities are investigating potential...
-
Cramer: Valeant Is A 'Great Mystery'
Monday, March 21, 2016 - 2:26pm | 398Read More...Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading up more than 10 percent on Monday afternoon, after the company announced that CEO J. Michael Pearson was leaving, and that billionaire activist Bill Ackman had been appointed as a board director. The company also said it would...
-
Former Valeant CFO: I Did Not Engage In Improper Conduct
Monday, March 21, 2016 - 11:20am | 400Read More...On the back of news from Valeant Pharmaceuticals Intl Inc (NYSE: VRX) regarding changes to its board of directors, former CFO Howard Schiller has defended his decision to not step down from the board. In a Monday press release, the company outlined upcoming changes, including the voluntary...
-
Valeant Names Howard Schiller As Interim CEO As Mike Pearson Remains In The Hospital
Wednesday, January 6, 2016 - 11:10am | 261Read More...Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading lower by more than 9 percent early Wednesday before erasing all of the losses and trading in positive territory shortly after the opening bell. Valeant Pharmaceuticals announced that Howard B. Schiller has been named as interim...
